drugset / Trial / NCT05674877

Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection

NCT05674877

Phase 3 Completed 100 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This randomized clinical trial will investigate the opioid sparing effect of dexmedetomidine and ketmine infusion in cirrhotic patients undergoing liver resection

Timeline

Start
2022-12-01
Primary completion
2023-06-28
Completion
2023-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg
Comparator Ketamine Small molecule 0.25 mg/kg

Indications